Timing and why we’re all VCs
TechCrunch LA
FEBRUARY 20, 2019
Start writing down predictions about people, companies, and markets. From the article: Mithril had its best moment yet last week when a portfolio company, Auris Health, sold to Johnson & Johnson for more than $3 billion — returning at least $500 million to the fund. Quality tech news from around the web. What a boring mess.
202 
Let's personalize your content